• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly.

Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Pharmaceutical industry.
Impella® SmartAssist Platform

Impella® SmartAssist Platform Launches at ESC, Designed to Further Improve Patient Outcomes

Abiomed announces today that the Impella CP® with SmartAssist technology, which is designed to improve patient outcomes with advanced algorithms and simplified patient management, will be commercially available in Europe beginning at the European Society of Cardiology (ESC) Congress 2019 through a controlled roll out process at select sites.

Read more →
Gecko Biomedical Rebrands as TISSIUM

Gecko Biomedical Rebrands as TISSIUM

Gecko Biomedical, a privately-owned life science company developing fully synthetic, biomorphic programmable polymers, has announced it will change the company name to TISSIUM as part of an overall rebranding of the company.

Read more →
Vytronus LICU system in clinical development

Vytronus Reaches Enrollment Milestone in Clinical Trial of Automated Ultrasound Technology for Treatment of Persistent Atrial Fibrillation

Vytronus, Inc., a privately held medical device company developing novel technologies for the treatment of cardiac arrhythmias, announced today that its early feasibility study of automated ultrasound technology for the treatment of persistent atrial fibrillation recently passed the midpoint in patient enrollment and is on track for completion of enrollment in mid-2019.

Read more →

We use cookies to ensure you get the best experience on this website Privacy Policy